March 2, 2023

Product Stewardship, Supply Chain, and Downstream User Engagement — A Conversation with Catherine M. Croke, DBA

Download transcript. This week, I had the pleasure of catching up with Dr. Catherine M. Croke, B&C’s and our consulting affiliate’s, The Acta Group, new Director of Product Stewardship and Regulatory Affairs. Catherine joined us recently from Evonik Corporation, where she was Senior Advocacy and Compliance Manager. Catherine’s diverse and truly extraordinary background working for industrial chemical companies in a variety of science, business, and advocacy roles have made...
February 16, 2023

Health Canada’s Update to Rev 7/8 of GHS — A Conversation with Karin F. Baron

Download transcript. This week, I welcomed back to the studio Karin F. Baron, Director of Hazard Communication and International Registration Strategy at B&C and our consulting affiliate, The Acta Group. During this 100th All Things Chemical podcast, Karin and I discuss the very important recently released amendments to the Canadian Hazardous Products Regulations (HPR). The amendments are intended to align the HPR with the seventh revised edition (Rev 7) of the United Nations (UN)...
February 2, 2023

What to Expect on Capitol Hill and at EPA OCSPP in 2023 — A Conversation with Jim Aidala

Download transcript. This week, I sat down with Jim Aidala, Senior Government Affairs Consultant at B&C and its consulting affiliate, The Acta Group. We discuss what to expect in 2023 from Capitol Hill and the U.S. Environmental Protection Agency’s (EPA) Office of Chemical Safety and Pollution Prevention (OCSPP) when it comes to key chemical matters. Jim is, of course, one of the country’s most talented pesticide experts and, as a former Assistant Administrator of what...
January 19, 2023

What to Expect in Chemicals Policy and Regulation in 2023 — A Conversation with Richard E. Engler, Ph.D.

Download transcript. This week, Dr. Richard E. Engler, Director of Chemistry for B&C and The Acta Group (Acta®), our consulting affiliate, returned to the studio to discuss what to expect in Toxic Substances Control Act (TSCA) regulation in the New Year. While we cannot predict with precision, we know 2023 will be a consequential year for several reasons: the first final risk management rule will be issued, the final per- and polyfluoroalkyl substance (PFAS) reporting rule...
January 5, 2023

EPA Adds Two New Chemical Categories: What It Means to Chemical Innovators — A Conversation with Richard E. Engler, Ph.D.

Download Transcript This week, Dr. Richard E. Engler, Director of Chemistry for B&C and The Acta Group, our consulting affiliate, returned to the studio to discuss the U.S. Environmental Protection Agency’s (EPA) bold moves in developing new chemical categories to help streamline the review of new chemicals under Toxic Substances Control Act (TSCA) Section 5. While the categorical approach to new chemical review is by no means new, it has stalled out in recent years, and...
December 8, 2022

TSCA Regulation of Articles: The Saga Continues — A Conversation with Richard E. Engler, Ph.D.

Download transcript. This week, Dr. Richard E. Engler, Director of Chemistry for B&C and The Acta Group, our consulting affiliate, returned to the studio to discuss the stubbornly vexatious problem of TSCA’s regulation of articles, a fancy name for products or finished goods. Most listeners to the podcast appreciate that this U.S. Environmental Protection Agency (EPA) Administration has specifically applied TSCA regulations to articles far more than in decades past. This policy pivot...
November 10, 2022

Keeping up with CLP Changes — A Conversation with Karin F. Baron

Download transcript. This week, I welcomed back to the studio Karin F. Baron, Senior Regulatory Consultant at B&C and our consulting affiliate, The Acta Group. Karin and I discuss the controversial changes proposed by the European Commission to the regulation on classification, labeling, and packaging of substances and mixtures, better known as the CLP regulation. As our listeners know, no one knows this space better than Karin Baron. Karin explains why the proposed changes are likely...
October 27, 2022

Biotech’s Emergence in the EU and Globally — A Conversation with Dr. Claire Skentelbery

Download transcript. This week, I sat down with Dr. Claire Skentelbery, Director General, EuropaBio — The European Association for Bioindustries. Many of you may know Claire from her prior role as Director General of the Nanotechnology Industries Association, where she energized that Brussels-based trade association to new and exciting heights. Claire has brought her considerable scientific, science policy, and trade association management skills to EuropaBio at an exciting time, as...
October 13, 2022

Misunderstood: The Excise Tax No One Likes or Understands — A Conversation with Douglas Charnas and Richard E. Engler, Ph.D.

Download transcript. This week I sat down with Doug Charnas, a nationally- recognized corporate and tax attorney and partner at McGlinchey, in its Washington, D.C. offices, and our own Dr. Richard Engler, Director of Chemistry at Bergeson & Campbell and at our consulting affiliate, The Acta Group. We discuss the recently reinstated Superfund Tax, which entities the tax applies to, what exactly is a taxable chemical and how to distinguish between taxable chemicals and taxable...
September 29, 2022

The New Era of Smarter Food Safety — A Conversation with Karin Baron

Download transcript. This week, I welcomed back to the studio Karin F. Baron, Senior Regulatory Consultant at B&C and our consulting affiliate, The Acta Group. Karin and I discuss the U.S. Food and Drug Administration’s (FDA) initiative called the New Era of Smarter Food Safety. The goal of this initiative is to diminish the number of foodborne illness, which, surprisingly, has not diminished since the Food Safety Modernization Act was enacted 11 years ago. We discuss...